Aadi Bioscience Inc (AADI)
1.675
-0.10
(-5.90%)
USD |
NASDAQ |
Apr 25, 16:00
1.675
0.00 (0.00%)
After-Hours: 20:00
Aadi Bioscience Total Assets (Quarterly): 132.42M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 132.42M |
| September 30, 2023 | 139.66M |
| June 30, 2023 | 151.23M |
| March 31, 2023 | 170.65M |
| December 31, 2022 | 184.24M |
| September 30, 2022 | 194.10M |
| Date | Value |
|---|---|
| June 30, 2022 | 128.64M |
| March 31, 2022 | 142.32M |
| December 31, 2021 | 157.91M |
| September 30, 2021 | 168.77M |
| December 31, 2020 | 18.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
18.82M
Minimum
Dec 2020
194.10M
Maximum
Sep 2022
144.43M
Average
151.23M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Aquestive Therapeutics Inc | 57.42M |
| 89bio Inc | 596.27M |
| NovaBay Pharmaceuticals Inc | 9.034M |
| Palatin Technologies Inc | 13.55M |
| iBio Inc | 34.02M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 27.23M |
| Shareholders Equity (Quarterly) | 105.20M |
| Current Ratio | 4.720 |